Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
Kathryn Goggin, Jackson Londeree, Alexandra F. Freeman, Rouba Garro, Roshan George
Abstract
We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.
Topics & Concepts
MedicinePeritoneal dialysisKidney diseaseEnd-stage kidney diseaseEnd stage renal diseaseStage (stratigraphy)DiseaseDermatologyImmunologyInternal medicineBiologyPaleontologyAntifungal resistance and susceptibilityFungal Infections and StudiesImmunodeficiency and Autoimmune Disorders